Wesana Health Reports Q3 2021 Financial Results Post published:November 29, 2021 Post category:Press Release
Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments Post published:November 19, 2021 Post category:Press Release
Wesana Health Commits Funding of $1.5 Million To Support MAPS’ Research Pipeline Post published:September 14, 2021 Post category:Press Release
Wesana Health Announces Closing of PsyTech Acquisition Post published:September 9, 2021 Post category:Press Release
Distinguished Psychedelic Researcher, Professor of Psychiatry and Neuroscience, Rachel Yehuda, PhD, Joins Wesana Health Scientific Advisory Board Post published:August 31, 2021 Post category:Press Release
Wesana Health Highlights Recent Appointments to Board of Directors Post published:August 19, 2021 Post category:Press Release
Wesana Health Commences Functional Animal Study for Treatment of Traumatic Brain Injury Post published:August 11, 2021 Post category:Press Release
Ian Burnstein Joins Wesana Health Advisory Board Post published:July 14, 2021 Post category:Press Release
Wesana Health Announces Definitive Agreement to Acquire PsyTech Inc. Post published:July 13, 2021 Post category:Press Release
Wesana Health Partners with University of South Carolina Post published:June 24, 2021 Post category:Press Release